FOS and hepatocellular carcinoma: The inhibition of SMMC-7721 in HCC cells in vitro is dose- and time-dependent and can significantly downregulate several oncogenes such as fos, myc, and ras and upregulate the expression of oncogenes represented by NF-2 and the phosphokinase Map2k6 (Zhang et al., 2007).